October 7, 2009
WASHINGTON - The E.P.A. is launching this year a comprehensive new evaluation of the pesticide atrazine to determine its effects on humans. At the end of this process, the agency will decide whether to revise its current risk assessment of the pesticide and whether new restrictions are necessary to better protect public health. One of the most widely used agricultural pesticides in the U.S., atrazine can be applied before and after planting to control broadleaf and grassy weeds. E.P.A. will evaluate the pesticide's potential cancer and non-cancer effects on humans. Included in this new evaluation will be the most recent studies on atrazine and its potential association with birth defects, low birth weight, and premature births.
"One of Administrator Jackson's top priorities is to enhance the way E.P.A. manages and assesses the risk of chemicals, including pesticides, and as part of that effort, we are taking a hard look at the decision made by the previous administration on atrazine," said Steve Owens, assistant administrator for EPA's Office of Prevention, Pesticides and Toxic Substances. "Our examination of atrazine will be based on transparency and sound science, including independent scientific peer review, and will help determine whether a change in EPA's regulatory position on this pesticide is appropriate."
During the new evaluation, E.P.A. will consider the potential for atrazine cancer and non-cancer effects, and will include data generated since 2003 from lab and population studies. To be certain that the best science possible is used in its atrazine human health risk assessment and ensure transparency, E.P.A. will seek advice from the independent Scientific Advisory Panel (SAP) established under the Federal Insecticide, Fungicide and Rodenticide Act.
E.P.A. will engage the SAP to evaluate the human health effects of atrazine over the coming year. Below is the timeline:
· November 2009: E.P.A. will present SAP its project for the new atrazine evaluation.
· February 2010: E.P.A. will present and seek scientific peer review of its suggested project for incorporating population studies into the atrazine risk assessment.
· April 2010: E.P.A. will present and seek peer review of its evaluation of atrazine non-cancer effects based on animal lab toxicology studies, selection of safety factors in the risk assessment, and the sampling design currently used to monitor drinking water in community water systems.
· September 2010: E.P.A. will present and seek peer review of its evaluation of atrazine cancer and non-cancer effects based on animal toxicology studies and epidemiology studies. This review is intended to include the most recent results from the National Cancer Institute's Agricultural Health Study, anticipated for publication in 2010.
At the conclusion of this process, E.P.A. will ask the SAP to review atrazine's potential effects on amphibians and aquatic ecosystems. The SAP meetings will be open to the public. In addition to the scientific review of the effects of atrazine, E.P.A. projects to meet with interested groups to explore better ways to inform the public more quickly about results of atrazine drinking water monitoring.
More information on atrazine:
http://www.epa.gov/pesticides/reregistration/atrazine/atrazine_update.htm More information on the SAP meetings:
http://www.epa.gov/scipoly/sap/index.htm
